A detailed history of Black Rock Inc. transactions in Insmed Inc stock. As of the latest transaction made, Black Rock Inc. holds 11,799,701 shares of INSM stock, worth $791 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,799,701
Previous 11,492,282 2.68%
Holding current value
$791 Million
Previous $356 Million 10.11%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$25.72 - $29.94 $7.91 Million - $9.2 Million
307,419 Added 2.68%
11,799,701 $320 Million
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $25.8 Million - $35 Million
1,101,592 Added 10.6%
11,492,282 $356 Million
Q3 2023

Nov 13, 2023

BUY
$19.86 - $26.93 $2.63 Million - $3.57 Million
132,408 Added 1.29%
10,390,690 $262 Million
Q2 2023

Aug 11, 2023

BUY
$16.44 - $21.1 $2.81 Million - $3.61 Million
170,862 Added 1.69%
10,258,282 $216 Million
Q1 2023

May 12, 2023

SELL
$16.26 - $21.73 $16.7 Million - $22.3 Million
-1,026,367 Reduced 9.24%
10,087,420 $172 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $31.4 Million - $42.8 Million
1,850,136 Added 19.97%
11,113,787 $222 Million
Q3 2022

Nov 14, 2022

SELL
$20.88 - $28.21 $3.79 Million - $5.12 Million
-181,458 Reduced 1.92%
9,263,651 $200 Million
Q2 2022

Aug 12, 2022

BUY
$17.07 - $25.71 $1.42 Million - $2.13 Million
82,926 Added 0.89%
9,445,109 $186 Million
Q1 2022

May 12, 2022

BUY
$20.42 - $28.13 $899,562 - $1.24 Million
44,053 Added 0.47%
9,362,183 $220 Million
Q4 2021

Feb 10, 2022

BUY
$25.89 - $33.45 $2.78 Million - $3.59 Million
107,257 Added 1.16%
9,318,130 $254 Million
Q3 2021

Nov 09, 2021

BUY
$22.46 - $29.47 $12.4 Million - $16.2 Million
550,751 Added 6.36%
9,210,873 $254 Million
Q2 2021

Aug 11, 2021

BUY
$24.17 - $36.01 $209 Million - $312 Million
8,660,122 New
8,660,122 $246 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.08B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.